Shree Pacetronix Limited announced its financial results for the fiscal year ending March 31, 2026. The company reported a substantial increase in profitability, with Net Profit soaring by 211.29% to ₹301.74 Lakhs. This growth was driven by improved operational performance and effective cost management, resulting in a significantly higher Return on Equity and Net Profit Margin compared to the previous year.
Shree Pacetronix Reports Strong FY26 Performance
Shree Pacetronix Limited has revealed its financial performance for the fiscal year ended March 31, 2026. The company demonstrated robust growth, with its Net Profit Margin increasing by 211.29% to 13.95%, a significant jump from 4.48% in the previous year. This substantial improvement in profitability is primarily attributed to the company’s enhanced operational efficiency, strategic cost management, and sustained demand for its cardiac pacing solutions.
Key Financial Highlights
The company’s Return on Net Worth also saw a considerable increase, rising to 17.18% for FY 2025-26, up from 5.58% in FY 2024-25. This reflects efficient capital utilization and sustained profitability. The improved financial performance is supported by an increase in the company’s average net worth, driven by profit retention and stronger reserves. The management remains focused on optimizing returns through strategic growth initiatives and prudent financial planning to enhance shareholder value.
Operational Efficiency and Market Presence
Operationally, Shree Pacetronix continued to focus on strengthening its core business of manufacturing and supplying cardiac pacemakers. The company achieved an operational revenue of ₹2163.69 Lakhs, reflecting strong performance and expanding presence in both domestic and international markets. Efforts were also directed towards improving production efficiency and responding to evolving market and customer requirements, while maintaining stringent quality standards and regulatory compliance.
Source: BSE
